Soleno Therapeutics Stock Options

SLNO Stock  USD 46.88  0.89  1.94%   
Soleno Therapeutics' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 1.19 with a put-to-call open interest ratio of 0.64 over 25 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on April 17th 2025. The total put volume is at 3.0, with calls trading at the volume of 44.0. This yields a 0.07 put-to-call volume ratio.

Open Interest Against April 17th 2025 Option Contracts

The chart above shows Soleno Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Soleno Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Soleno Therapeutics' option, there is no secondary market available for investors to trade.

Soleno Therapeutics Maximum Pain Price Across 2025-04-17 Option Contracts

Max pain occurs when Soleno Therapeutics' market makers reach a net positive position across all Soleno Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, Soleno Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Soleno Therapeutics

Analyzing Soleno Therapeutics' in-the-money options over time can help investors to take a profitable long position in Soleno Therapeutics regardless of its overall volatility. This is especially true when Soleno Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Soleno Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Soleno Therapeutics' stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Soleno Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Soleno Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Soleno Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Soleno Stock moves the wrong way.

Soleno Therapeutics In The Money Call Balance

When Soleno Therapeutics' strike price is surpassing the current stock price, the option contract against Soleno Therapeutics stock is said to be in the money. When it comes to buying Soleno Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Soleno Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Soleno Current Options Market Mood

Soleno Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Soleno Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Soleno Therapeutics' options investors are not very successful. Soleno Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Soleno contract

Base on the Rule 16, the options market is currently suggesting that Soleno Therapeutics will have an average daily up or down price movement of about 0.0744% per day over the life of the 2025-04-17 option contract. With Soleno Therapeutics trading at USD 46.88, that is roughly USD 0.0349. If you think that the market is fully incorporating Soleno Therapeutics' daily price movement you should consider buying Soleno Therapeutics options at the current volatility level of 1.19%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Soleno Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Soleno calls. Remember, the seller must deliver Soleno Therapeutics stock to the call owner when a call is exercised.

Soleno Therapeutics Option Chain

When Soleno Therapeutics' strike price is surpassing the current stock price, the option contract against Soleno Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Soleno Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Soleno. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Soleno. It also shows strike prices and maturity days for a Soleno Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
SLNO250417C00030000330.020.6 - 24.321.0In
Call
SLNO250417C000400002740.014.5 - 17.411.2In
Call
SLNO250417C000450003745.011.1 - 13.912.0In
Call
SLNO250417C00050000181250.07.8 - 11.19.6Out
Call
SLNO250417C00055000286755.06.3 - 8.77.03Out
Call
SLNO250417C00060000260.04.2 - 7.96.5Out
Call
SLNO250417C0006500058165.04.0 - 5.74.3Out
Call
SLNO250417C00070000249470.02.1 - 4.22.99Out
Call
SLNO250417C000750004875.01.05 - 4.31.3Out
Call
SLNO250417C00080000480.00.25 - 4.90.6Out
Call
SLNO250417C000850004785.00.0 - 1.50.91Out
 Put
SLNO250417P000225009622.53.2 - 3.73.5Out
 Put
SLNO250417P0002500081125.03.7 - 5.64.0Out
 Put
SLNO250417P00030000255930.04.5 - 6.95.0Out
 Put
SLNO250417P0003500023835.03.9 - 8.55.8Out
 Put
SLNO250417P0004000074740.05.5 - 10.07.2Out
 Put
SLNO250417P0004500031345.07.6 - 12.07.8Out
 Put
SLNO250417P000500004050.011.5 - 13.912.2In
 Put
SLNO250417P0005500028255.012.6 - 16.99.5In
 Put
SLNO250417P00060000360.016.2 - 20.114.3In
 Put
SLNO250417P00065000065.019.6 - 23.819.6In
 Put
SLNO250417P00070000070.023.6 - 27.523.6In
 Put
SLNO250417P00075000075.027.6 - 32.027.6In
 Put
SLNO250417P00080000080.032.0 - 36.432.0In
 Put
SLNO250417P00085000085.036.1 - 40.736.1In

Soleno Therapeutics Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Soleno Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Soleno Total Stockholder Equity

Total Stockholder Equity

190.19 Million

At this time, Soleno Therapeutics' Total Stockholder Equity is very stable compared to the past year.

Soleno Therapeutics Corporate Management

Kristen MSSenior OperationsProfile
Dr MBASenior DevelopmentProfile
Patricia MPHSenior AffairsProfile
PharmD MBASenior AffairsProfile
Meredith MBAChief OfficerProfile
Anish MDCEO and PresidentProfile
When determining whether Soleno Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Soleno Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Soleno Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Soleno Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Soleno Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.79)
Return On Assets
(0.48)
Return On Equity
(0.91)
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.